- Home
- NTIP vs BEAT Comparison
NTIP vs BEAT Comparison
Compare NTIP & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTIP | BEAT |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | United States | United States |
| Employees | N/A | 17 |
| Industry | Multi-Sector Companies | Retail: Computer Software & Peripheral Equipment |
| Sector | Miscellaneous | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6M | 31.6M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | NTIP | BEAT |
|---|---|---|
| Price | $1.62 | $0.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 49.1K | ★ 660.6K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | ★ 7.30% | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $150,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 50.00 | N/A |
| 52 Week Low | $1.24 | $0.51 |
| 52 Week High | $1.75 | $4.00 |
Technical Indicators
Market Signals| Indicator | NTIP | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 69.28 | 33.62 |
| Support Level | $1.39 | N/A |
| Resistance Level | $1.67 | $0.79 |
| Average True Range (ATR) | 0.04 | 0.06 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 95.83 | 4.14 |
Price Performance
Historical ComparisonAbout NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.